Skip to main content

Table 1 Patient and tumor characteristics

From: Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma

Specimen description

Stage

Age (years)

TNM

Nuclear grade

ER

PR

p53 status

HER2/neu

Initial sample

   43 DCIS (pure)

0

37

T3N0M0

ND

-

-

+

ND

   44 DCIS (pure)

0

44

ToN0M0

2 and 3

+

+

-

+

   46 DCIS (pure)

0

43

T2N0M0

3

+

+

-

+ (3+)

   48 DCIS (pure)

0

52

T2N0M0

3

+

+

-

+ (3+)

   49 DCIS (pure)

0

58

TicN0M0

3 (High grade)

-

-

-

+ (3+)

   2 DCIS

IIa

48

T2N0M0

3

+

+

+

+

   13 DCIS

IIa

75

T2N0M0

2

+

+

+

+ (2+)

   25 DCIS

IIa

34

T2N0M0

3

+

+

+

+ (3+)

   33 DCIS

I

38

T1cN0M0

3

+

-

-

-

   45 DCIS

I

55

T1N0M0

3

-

-

+

+ (3+)

   66 DCIS

IIIb

44

T4bN1M0

3

+

+

+

- (1+)

   69 DCIS

IIb/IIIa

57

T2N1M0/pT2N2M0

2

+

+

ND

+ (2+)

   75 DCIS

IIb

43

pT2N0M0

IDC 2/DCIS 3

-

-

+

+ (3+)

   85 DCIS

I

73

T1cN0M0 pT3N0M0

2

+

+

-

+ (2+)

   86 DCIS

ND

46

T2N1M0

3

+

+

+

+ (2+)

   87 DCIS

IIa

48

T2N1M0

3

-

-

-

+ (2+)

   1 IDC

IIa

45

T2N0M0

2

-

-

-

+ (3+)

   3 IDC

IIa

43

T1cN0M0

3

+

-

-

+ (3+)

   24 IDC

IIa

54

T2N0M0

3

+

+

+

+ (3+)

   50 IDC

III b

71

T4N2M0

3

+

+

+

+ (2+)

   51 IDC

II a

43

initial T2N0M0

3

-

ND

ND

+ (3+)

   53 IDC

III a

43

T2N2M0

3

+

+

ND

+ (2+)

   56 IDC

I

ND

ND

ND

ND

ND

ND

ND

   80 IDC

IIa

44

pT1cpN1M0

3

+

+

-

-

   81 IDC

IIb

31

T2N1M0

3

-

-

+

+ (3+)

   83 IDC

IIa

48

T2N0M0

2

+

+

-

+ (2+)

Independent group of DCIS/IDC samples

   1 DCIS

ND

58

T1N0M0

3

+

+

+

+ (2+)

   2 DCIS

ND

40

T1N1M0

3

+

+

-

+ (2+)

   3 DCIS

ND

27

T1N0M0

1 (Low grade)

ND

ND

ND

ND

   4 DCIS

ND

53

ND

3 (High grade)

+

+

+

+ (2+)

   5 DCIS

ND

51

T1N0M0

2

+

+

ND

+ (2+)

   6 DCIS

III a

54

T3N1M0

3 (High grade)

-

-

ND

ND

   8 DCIS

ND

52

T2N1M0

3

-

-

+

+ (3+)

   9 DCIS

ND

38

T1N1M0

3 (High grade)

-

-

+

- (1+)

   3 DCIS

ND

39

T2N0M0

ND

+

+

+

-

   8 DCIS

ND

49

T2N0M0

ND

+

+

ND

-

   15 DCIS

II b

69

T2N1M0

ND

+

+

ND

+ (2+)

  1. Unless otherwise stated, 'DCIS' means in situ component of DCIS-IDC. DCIS, ductal carcinoma in situ; DCIS-IDC, ductal carcinoma in situ with co-existing invasive ductal carcinoma; ER, estrogen receptor; IDC, invasive ductal carcinoma; ND, not determined; PR, progesterone receptor; TNM, tumor size, nodal status and metastasis.